Showing results (791-800 of 813) with videos related to
Sort By:
Pageof 82
Expert Opinion on Drug Discovery|July 10, 2023
MEDIATE - Molecular DockIng at homE: Turning collaborative simulations into therapeutic solutionsGiulio Vistoli, Candida Manelfi, Carmine Talarico, et al.Journal of Medicinal Chemistry|March 6, 2026
Design and Synthesis of Pyrrolo[3,4-<i>d</i>]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse ModelNian-Dong Mao, Zi Hui, Chen-Chen Wang, et al.Environment and Planning. B, Urban Analytics and City Science|April 1, 2026
Global Healthy and Sustainable City Indicators: Collaborative development of an open science toolkit for calculating and reporting on urban indicators internationallyCarl Higgs, Melanie Lowe, Billie Giles-Corti, et al.Bioorganic & Medicinal Chemistry Letters|April 2, 2010
Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulationXiang-Yang Ye, Stephanie Chen, Hao Zhang, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 11, 2022
Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learningRhodri H Davies, João B Augusto, Anish Bhuva, et al.Acta Pharmacologica Sinica|August 5, 2021
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike proteinLin Wang, Yan Wu, Sheng Yao, et al.Journal of Geriatric Cardiology : JGC|March 6, 2023
His bundle pacing versus left bundle branch pacing on ventricular function in atrial fibrillation patients referred for pacing: a prospective crossover comparisonYang Ye, Bo Gao, Yuan Lv, et al.Acta Pharmacologica Sinica|August 2, 2020
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredientsHai-Xia Su, Sheng Yao, Wen-Feng Zhao, et al.Journal of Medicinal Chemistry|September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal TumorsJason G Kettle, Rana Anjum, Evan Barry, et al.Journal of Medicinal Chemistry|June 22, 2017
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT<sub>2C</sub> Receptor AgonistsJoseph Carpenter, Ying Wang, Gang Wu, et al.Pageof 82